Worldwide, scientists are engaged in an effort to transfer the human brain to an avatar. Their goal is to transform humans into digital beings and thereby free them from the curse of aging, and from death. So do we really need a body? Can we become immortal?
Through interviews with leading psychologists and scientists, Neurons to Nirvana explores the history of four powerful psychedelic substances (LSD, Psilocybin, MDMA and Ayahuasca) and their previously established medicinal potential. Strictly focusing on the science and medicinal properties of these drugs, Neurons to Nirvana looks into why our society has created such a social and political bias against even allowing research to continue the exploration of any possible positive effects they can present in treating some of today's most challenging afflictions.
2013 • Brain
Part 1 of this eight-part series of shorts introduces the world of the visual scientist. Beyond boggling your mind, Prof. Arthur Shapiro explains how and why you see what you see -- and what part of what you see is actually "real", as opposed to how your mind fills in the blanks.
Michio Kaku, best-selling author and physicist, imagining the not-so-distant future, offers his projections for advancements in humanity's understanding of the brain over the next century. Kaku envisions a world in which progress in neuroscience and biotechnology will demystify the human mind.
Alzheimer’s disease strikes at the core of what makes us human: our capacity to think, to love, and to remember. The disease ravages the minds of over 40 million victims worldwide, and it is one of the greatest medical mysteries of our time. Join investigators as they gather clues and attempt to reconstruct the molecular chain of events that ultimately leads to dementia, and follow key researchers in the field who have helped to develop the leading theories of the disease. Along the way, meet individuals from all walks of life who will reveal what it’s like to struggle with Alzheimer’s. Among them, members of a unique Colombian family who have learned that their genetic predisposition all but guarantees early onset Alzheimer’s. Yet there may be hope. Join these courageous patients participating in clinical trials, and then go behind the scenes of the major drug trials to see how researchers target and test therapies that may slow and even prevent Alzheimer’s.
We humans love to build, create, and organize. So why do we also love to destroy things? Can violently breaking stuff really help to calm us down, or does it just make us more angry? In this episode of Mind Field, I take a hard look at our urge to destroy.